Extracellular domains drive homo- but not heterodimerization of erbB receptors

EMBO Journal

Volumn 19, Issue 17, 2000, Pages 4632-4643

  Ferguson, K M ^a   Darling, P J ^a   Mohan, M J ^a   Macatee, T L ^a   Lemmon, M A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dimerization; Growth factor; Scattering; Signaling; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; OLIGOMER; PROTEIN TYROSINE KINASE;

ARTICLE; DIMERIZATION; ENZYME BINDING; ENZYME SPECIFICITY; ENZYME STABILITY; GENE CONTROL; GENE INDUCTION; OLIGOMERIZATION; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION;

EID: 0034282556     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.17.4632     Document Type: Article

References (51)

1. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
2. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant
3. Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
4. A Neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
5. HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers
6. Formation of a high-affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4
7. Secondary dimerization between members of the epidermal growth factor receptor family
8. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation
9. Interaction between proteins localized in membranes
10. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
11. Epidermal growth factor binding induces a conformational change in the external domain of its receptor
12. The secreted form of the epidermal growth factor receptor: Characterization and crystallization of the receptor-ligand complex
13. Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
14. Dimerization of cell surface receptors in signal transduction
15. Identification of heregulin, a specific activator of p185(erbB2)
16. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation in living cells
17. Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3
18. Proxy activation of protein erbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction
19. Autoregulatory mechanisms in protein-tyrosine kinases
20. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain
21. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation
22. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation
23. Binding specificities of egf domains for ErbB receptors
24. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
25. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB2 protein in the mammary tumor cell line SKBR-3
26. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor
27. Regulation of signal transduction and signal diversity by receptor oligomerization
28. Two EGF molecules contribute additively to stabilization of the EGFR dimer
29. Statistical determination of the average values of the extinction coefficient of tryptophan and tyrosine in native proteins
30. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: A mechanism of interreceptor kinase activation and transphosphorylation
31. Specificity within the EGF family/ErbB receptor family signaling network
32. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family
33. The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor and amphiregulin to Neu, ErbB-3 and ErbB-4
34. Local aggregation of hormone-receptor complexes is required for activation by epidermal growth factor
35. Receptor aggregation as a mechanism for transmembrane signaling: Models for hormone action
36. SH2/SH3 signaling proteins
37. Growth factor signaling by receptor tyrosine kinases
38. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
39. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)
40. SH2 domains recognize specific phosphopeptide sequences
41. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses
42. EGF-stimulated tyrosine-phosphorylation of p185(neu): A potential model for receptor interactions
43. Bivalence of EGF-like ligands drives the ErbB signaling network
44. Intermolecular association of the p185(neu) protein and EGF modulates EGF receptor function
45. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors
46. Light scattering and the absolute characterization of macromolecules
47. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation
48. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
49. Transformation of NIH3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2
50. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation